[(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate

C35H62N2O2 — CID 70021090

IUPAC[(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate
SMILESCCNCCCCNCC(=O)OC1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2[C@H](C)CCCC(C)C)C1
InChIInChI=1S/C35H62N2O2/c1-7-36-21-8-9-22-37-24-33(38)39-28-17-19-34(5)27(23-28)13-14-29-31-16-15-30(26(4)12-10-11-25(2)3)35(31,6)20-18-32(29)34/h13,25-26,28-32,36-37H,7-12,14-24H2,1-6H3/t26-,28?,29?,30-,31?,32?,34+,35-/m1/s1
InChIKeyLXEPPHIYBQYLIL-GRHZLFEWSA-N
MW542.89 g/mol
LogP7.92
Rot. Bonds14

About [(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate

[(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate (PubChem CID 70021090) has the molecular formula C35H62N2O2 and a molecular weight of 542.89 g/mol. Its IUPAC name is [(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate.

Molecular Properties

Compound Name[(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate
PubChem CID70021090
Molecular FormulaC35H62N2O2
Molecular Weight542.89 g/mol
Exact Mass542.48
IUPAC Name[(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate
SMILESCCNCCCCNCC(=O)OC1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2[C@H](C)CCCC(C)C)C1
InChIInChI=1S/C35H62N2O2/c1-7-36-21-8-9-22-37-24-33(38)39-28-17-19-34(5)27(23-28)13-14-29-31-16-15-30(26(4)12-10-11-25(2)3)35(31,6)20-18-32(29)34/h13,25-26,28-32,36-37H,7-12,14-24H2,1-6H3/t26-,28?,29?,30-,31?,32?,34+,35-/m1/s1
InChIKeyLXEPPHIYBQYLIL-GRHZLFEWSA-N
XLogP7.92
TPSA50.36 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds14
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500542.89
LogP ≤ 57.92
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate?
The IUPAC name of [(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate (CID 70021090) is [(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate.
What is the SMILES notation for [(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate?
The canonical SMILES for [(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate is CCNCCCCNCC(=O)OC1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2[C@H](C)CCCC(C)C)C1.
What is the InChIKey of [(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate?
The InChIKey is LXEPPHIYBQYLIL-GRHZLFEWSA-N. The full InChI is InChI=1S/C35H62N2O2/c1-7-36-21-8-9-22-37-24-33(38)39-28-17-19-34(5)27(23-28)13-14-29-31-16-15-30(26(4)12-10-11-25(2)3)35(31,6)20-18-32(29)34/h13,25-26,28-32,36-37H,7-12,14-24H2,1-6H3/t26-,28?,29?,30-,31?,32?,34+,35-/m1/s1.
What are the key properties of [(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate?
[(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate has a molecular weight of 542.89 g/mol, XLogP of 7.92, 14 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-(ethylamino)butylamino]acetate is sourced from PubChem (CID 70021090), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).